3-(1H-benzimidazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-(1,3-benzothiazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(6-chloro-1,3-benzothiazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(5-chloro-1,3-benzoxazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]-3-[(5-methoxy-1,3-benzothiazol-2-yl)sulfanyl]pyrazin-2-one
C116H116Cl2N16O17S8 — CID 158712085
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(1H-benzimidazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-(1,3-benzothiazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(6-chloro-1,3-benzothiazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(5-chloro-1,3-benzoxazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]-3-[(5-methoxy-1,3-benzothiazol-2-yl)sulfanyl]pyrazin-2-one
3-(1H-benzimidazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-(1,3-benzothiazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(6-chloro-1,3-benzothiazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(5-chloro-1,3-benzoxazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]-3-[(5-methoxy-1,3-benzothiazol-2-yl)sulfanyl]pyrazin-2-one (PubChem CID 158712085) has the molecular formula C116H116Cl2N16O17S8 and a molecular weight of 2333.74 g/mol. Its IUPAC name is 3-(1H-benzimidazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-(1,3-benzothiazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(6-chloro-1,3-benzothiazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(5-chloro-1,3-benzoxazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]-3-[(5-methoxy-1,3-benzothiazol-2-yl)sulfanyl]pyrazin-2-one.
Molecular Properties
| Compound Name | 3-(1H-benzimidazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-(1,3-benzothiazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(6-chloro-1,3-benzothiazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(5-chloro-1,3-benzoxazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]-3-[(5-methoxy-1,3-benzothiazol-2-yl)sulfanyl]pyrazin-2-one |
|---|---|
| PubChem CID | 158712085 |
| Molecular Formula | C116H116Cl2N16O17S8 |
| Molecular Weight | 2333.74 g/mol |
| Exact Mass | 2330.58 |
| IUPAC Name | 3-(1H-benzimidazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-(1,3-benzothiazol-2-ylsulfanyl)-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(6-chloro-1,3-benzothiazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;3-[(5-chloro-1,3-benzoxazol-2-yl)sulfanyl]-1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]pyrazin-2-one;1-[4-(2,2-dimethylpropoxy)-3-methoxyphenyl]-3-[(5-methoxy-1,3-benzothiazol-2-yl)sulfanyl]pyrazin-2-one |
| SMILES | COc1cc(-n2ccnc(Sc3nc4cc(Cl)ccc4o3)c2=O)ccc1OCC(C)(C)C.COc1cc(-n2ccnc(Sc3nc4ccc(Cl)cc4s3)c2=O)ccc1OCC(C)(C)C.COc1cc(-n2ccnc(Sc3nc4ccccc4[nH]3)c2=O)ccc1OCC(C)(C)C.COc1cc(-n2ccnc(Sc3nc4ccccc4s3)c2=O)ccc1OCC(C)(C)C.COc1ccc2sc(Sc3nccn(-c4ccc(OCC(C)(C)C)c(OC)c4)c3=O)nc2c1 |
| InChI | InChI=1S/C24H25N3O4S2.C23H22ClN3O4S.C23H22ClN3O3S2.C23H24N4O3S.C23H23N3O3S2/c1-24(2,3)14-31-18-8-6-15(12-19(18)30-5)27-11-10-25-21(22(27)28)33-23-26-17-13-16(29-4)7-9-20(17)32-23;1-23(2,3)13-30-18-8-6-15(12-19(18)29-4)27-10-9-25-20(21(27)28)32-22-26-16-11-14(24)5-7-17(16)31-22;1-23(2,3)13-30-17-8-6-15(12-18(17)29-4)27-10-9-25-20(21(27)28)32-22-26-16-7-5-14(24)11-19(16)31-22;1-23(2,3)14-30-18-10-9-15(13-19(18)29-4)27-12-11-24-20(21(27)28)31-22-25-16-7-5-6-8-17(16)26-22;1-23(2,3)14-29-17-10-9-15(13-18(17)28-4)26-12-11-24-20(21(26)27)31-22-25-16-7-5-6-8-19(16)30-22/h6-13H,14H2,1-5H3;2*5-12H,13H2,1-4H3;5-13H,14H2,1-4H3,(H,25,26);5-13H,14H2,1-4H3 |
| InChIKey | IIVUZWSVRSYVPO-UHFFFAOYSA-N |
| XLogP | 27.25 |
| TPSA | 369.36 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 159 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2333.74 |
| LogP ≤ 5 | 27.25 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 40 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158712085 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.